⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VIR News
Vir Biotechnology, Inc. Common Stock
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
globenewswire.com
GTBP
VIR
ONCY
SNSE
Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight
globenewswire.com
INO
REGN
VIR
MRK
AMGN
ABT
QGEN
BDX
TMO
DHR
MYGN
ILMN
EXAS
BIO
Sotrovimab (Xevudy: Vir Biotechnology, GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
VIR
GSK
Form 8-K
sec.gov
VIR
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results
businesswire.com
VIR
Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
businesswire.com
VIR
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
businesswire.com
VIR
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
businesswire.com
VIR
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN ® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
businesswire.com
VIR
Form 8-K
sec.gov
VIR